Denali Therapeutics Inc (NAS:DNLI)
$ 24.77 0.88 (3.68%) Market Cap: 3.55 Bil Enterprise Value: 2.70 Bil PE Ratio: 0 PB Ratio: 2.56 GF Score: 60/100

Denali Therapeutics Inc (DNLI) Transcripts

  • 1